CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Placebo capsulesWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (5)

Name (Synonyms) Correlation
drug1837 Placebo Tablet Wiki 1.00
drug8 0.9% Sodium-chloride Wiki 1.00
drug1047 Heparin Wiki 0.71
drug262 Azithromycin Wiki 0.17
drug1086 Hydroxychloroquine Wiki 0.10

Correlated MeSH Terms (4)

Name (Synonyms) Correlation
D014947 Wounds and Injuries NIH 0.22
D055370 Lung Injury NIH 0.21
D055371 Acute Lung Injury NIH 0.10
D012128 Respiratory Distress Syndrome, Adult NIH 0.09

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Randomized Placebo-controlled Trial of Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19

Q-PROTECT is a placebo controlled randomized trial (RCT) to ascertain the efficacy of hydroxychloroquine (HC) alone or, in combination with azithromycin (AZ), in reducing viral load in patients with COVID 19.

NCT04349592 Covid19 Drug: Hydroxychloroquine Drug: Azithromycin Other: Placebo Tablet Other: Placebo capsules

Primary Outcomes

Description: Days

Measure: Proportion of virologically cured (PCR-negative status) as assessed on day six

Time: Day 6

Secondary Outcomes

Description: Days

Measure: virologic cure on other study days

Time: Day14 and Day 21

Description: Days

Measure: virologic semiquantitative analysis of changing viral load

Time: Day 1 to Day 21

Description: Days

Measure: proportion of initially symtomatic subjects with disappearance of clinical symptoms

Time: Day14 and Day 21

Description: Days

Measure: proportion of initially asymtomatic subjects with appearance of new clinical symptoms

Time: Day14 and Day 21

Description: grades

Measure: proportions of subjects with potentially medication- related adverse events

Time: 7 day

No related HPO nodes (Using clinical trials)